Cynthia T. Mazareas

Biotechnology and Life Sciences Practice

4.0 (1 reviews)

Boston, Massachusetts

6+ years experience

Updated: Jan 03, 2026

Contact Information

617-526-6000

https://www.wilmerhale.com/en/people/cynthia-mazareas

60 State Street Boston MA US

Create an account to contact this attorney

Claim this profile

Are you this attorney? Claim or manage this listing by signing in or creating an attorney account.

Attorney Login Claim Profile

Bio

Cynthia T. Mazareas is a top attorney recognized by Best Lawyers in the practice area(s) of Biotechnology and Life Sciences Practice. Cynthia T., who practices law in Boston, Massachusetts, has been recognized since 2019. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Cynthia T. is held by other top lawyers in the same geographic and legal practice area.

Local Legal Snapshot

Jurisdiction

Massachusetts

State Capital

Boston

Highest Court

Massachusetts Supreme Judicial Court

Bar Association

Massachusetts Bar Association

Typical Consultation

$150-$300

Typical Hourly Range

$250-$450/hr

Fee Model Notes

Hourly or flat-fee billing is common.

Estimates vary by market, complexity, urgency, and attorney experience.

Practice Areas

Biotechnology and Life Sciences Practice

Awards & Recognition

Recognized: Biotechnology and Life Sciences Practice
Practice Area: Securities / Capital Markets Law

Recognized in Best Lawyers since 2019

Education

Georgetown University, J.D., graduated 1993

Get Directions on Google Maps

Reviews

Rebecca Ortiz

3 months ago

Expert guidance for our biotech startup's funding round

Cynthia Mazareas provided excellent counsel during our Series B funding round. Her deep knowledge of securities law and capital markets, particularly within the biotechnology sector, was immediately apparent and gave our board immense confidence. She skillfully navigated complex regulatory requirements and her drafting was meticulous. While her billing rates reflect the high caliber of WilmerHale, and there were occasional delays in email responses during peak periods, the quality of her strategic advice was worth the investment. Her recognition in biotechnology and life sciences practice is well-deserved. We felt well-represented by someone who truly understands the intersection of science and finance.